Table 3 Two-way ANOVAs analysis for cyclin D and Ki67 counts in all treatment groups
From: Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice
| Â | Cyclin D p value | Ki67 p value |
|---|---|---|
Control vs LPS | < 0.05 | >  0.05 |
Control vs 12.5% LM | < 0.001 | < 0.0001 |
12.5% LM vs 12.5% LM | ||
 + 200 μM ibuprofen | < 0.0001 | < 0.0001 |
Control vs 6.25% LM | < 0.001 | < 0.001 |
6.25% LM Vs 6.25% LM | ||
 + 200 μM ibuprofen | < 0.001 | < 0.001 |
Control vs 6.25% MM | < 0.05 | >  0.05 |
6.25% MM Vs 6.25% MM | ||
 + 200 μM ibuprofen | >  0.05 | >  0.05 |
Control vs 12.5% MM | < 0.05 | < 0.05 |
12.5% MM Vs 12.5% MM | ||
 + 200 μM ibuprofen | < 0.05 | < 0.05 |